Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Hydrocodone bitartrate; ibuprofen - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrocodone bitartrate; ibuprofen and what is the scope of hydrocodone bitartrate; ibuprofen freedom to operate?

Hydrocodone bitartrate; ibuprofen
is the generic ingredient in three branded drugs marketed by Actavis Labs Fl Inc, Abbvie, Teva, Vintage Pharms, Sun Pharm Inds Inc, Amneal Pharms Ny, and Aurolife Pharma Llc, and is included in nine NDAs. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for hydrocodone bitartrate; ibuprofen. Twenty-two suppliers are listed for this compound.

Summary for Generic Name: hydrocodone bitartrate; ibuprofen

Drug Master File Entries: see list22
Suppliers / Packagers: see list22
Clinical Trials: see list233
Drug Prices:see low prices
DailyMed Link:hydrocodone bitartrate; ibuprofen at DailyMed

Pharmacology for Ingredient: hydrocodone bitartrate; ibuprofen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc
hydrocodone bitartrate; ibuprofen
TABLET;ORAL091633-001May 28, 2013ABRXNoNo► Subscribe► Subscribe
Vintage Pharms
hydrocodone bitartrate; ibuprofen
TABLET;ORAL077723-002Nov 6, 2006ABRXNoNo► Subscribe► Subscribe
hydrocodone bitartrate; ibuprofen
TABLET;ORAL076023-001Apr 11, 2003ABRXNoNo► Subscribe► Subscribe
Amneal Pharms Ny
hydrocodone bitartrate; ibuprofen
TABLET;ORAL076642-003Oct 19, 2007ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds Inc
hydrocodone bitartrate; ibuprofen
TABLET;ORAL091633-003May 28, 2013ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus